Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia. / Hølmkjær, Pernille; Vermehren, Charlotte; Holm, Anne; Rozing, Maarten Pieter; Høj, Kirsten; Overbeck, Gritt.

I: BMC Health Services Research, Bind 22, Nr. 1, 1582, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Hølmkjær, P, Vermehren, C, Holm, A, Rozing, MP, Høj, K & Overbeck, G 2022, 'Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia', BMC Health Services Research, bind 22, nr. 1, 1582. https://doi.org/10.1186/s12913-022-08961-9

APA

Hølmkjær, P., Vermehren, C., Holm, A., Rozing, M. P., Høj, K., & Overbeck, G. (2022). Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia. BMC Health Services Research, 22(1), [1582]. https://doi.org/10.1186/s12913-022-08961-9

Vancouver

Hølmkjær P, Vermehren C, Holm A, Rozing MP, Høj K, Overbeck G. Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia. BMC Health Services Research. 2022;22(1). 1582. https://doi.org/10.1186/s12913-022-08961-9

Author

Hølmkjær, Pernille ; Vermehren, Charlotte ; Holm, Anne ; Rozing, Maarten Pieter ; Høj, Kirsten ; Overbeck, Gritt. / Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia. I: BMC Health Services Research. 2022 ; Bind 22, Nr. 1.

Bibtex

@article{edd43b3681f54ac38b912f25a3265f04,
title = "Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia",
abstract = "INTRODUCTION: First-line treatment for behavioral and psychiatric symptoms of dementia is non-pharmacological. Still, psychotropic medication is widely used, despite its limited effect and harmful side-effects. More than half of all nursing home residents with dementia receive antidepressants, even though deprescribing is safe and feasible. Interventions to promote deprescribing of antidepressants in nursing homes are few and complex. To optimize the deprescribing process through an intervention, transparency for the development of the intervention is needed. We aim to describe the steps in the development and tailoring of an intervention targeting GPs, nursing home staff, and relatives to enhance collaboration on reducing the use of antidepressants in institutionalized older persons with dementia in Denmark.METHOD: A step-wise process guided by the core elements in the Medical Research Council constituted the tailoring process. Five steps were included; 1) a literature search, 2) interviews with stakeholders, 3) drafting the intervention prototype, 4) professionals' assessment of the intervention, and 5) refinement of the intervention. The steps were conducted from June 2020 to June 2022.RESULTS: Based on the literature search, interviews with stakeholders, and professionals' assessment of the intervention, four main themes were identified; 1) focusing on antidepressants, 2) importance of professional qualifications, 3) collaboration and communication, and 4) patient and relative involvement. They guided intervention development and refinement of the final intervention, which included 1) a case-based training course and 2) a dialog tool including a symptom assessment scale to be used in a structured consultation at the nursing home.CONCLUSION: This study presents a detailed account of the tailoring process for a complex intervention to optimize deprescribing of antidepressants for older persons with dementia at nursing homes. By presenting a thorough development process, we expect to achieve increased adherence to the intervention which is currently being tested in an ongoing cluster randomized controlled trial. The transparency of the process will also increase the future development of other similar complex interventions.",
keywords = "Humans, Aged, Aged, 80 and over, Nursing Homes, Antidepressive Agents/therapeutic use, Psychotropic Drugs/therapeutic use, Longitudinal Studies, Dementia/therapy",
author = "Pernille H{\o}lmkj{\ae}r and Charlotte Vermehren and Anne Holm and Rozing, {Maarten Pieter} and Kirsten H{\o}j and Gritt Overbeck",
note = "{\textcopyright} 2022. The Author(s).",
year = "2022",
doi = "10.1186/s12913-022-08961-9",
language = "English",
volume = "22",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia

AU - Hølmkjær, Pernille

AU - Vermehren, Charlotte

AU - Holm, Anne

AU - Rozing, Maarten Pieter

AU - Høj, Kirsten

AU - Overbeck, Gritt

N1 - © 2022. The Author(s).

PY - 2022

Y1 - 2022

N2 - INTRODUCTION: First-line treatment for behavioral and psychiatric symptoms of dementia is non-pharmacological. Still, psychotropic medication is widely used, despite its limited effect and harmful side-effects. More than half of all nursing home residents with dementia receive antidepressants, even though deprescribing is safe and feasible. Interventions to promote deprescribing of antidepressants in nursing homes are few and complex. To optimize the deprescribing process through an intervention, transparency for the development of the intervention is needed. We aim to describe the steps in the development and tailoring of an intervention targeting GPs, nursing home staff, and relatives to enhance collaboration on reducing the use of antidepressants in institutionalized older persons with dementia in Denmark.METHOD: A step-wise process guided by the core elements in the Medical Research Council constituted the tailoring process. Five steps were included; 1) a literature search, 2) interviews with stakeholders, 3) drafting the intervention prototype, 4) professionals' assessment of the intervention, and 5) refinement of the intervention. The steps were conducted from June 2020 to June 2022.RESULTS: Based on the literature search, interviews with stakeholders, and professionals' assessment of the intervention, four main themes were identified; 1) focusing on antidepressants, 2) importance of professional qualifications, 3) collaboration and communication, and 4) patient and relative involvement. They guided intervention development and refinement of the final intervention, which included 1) a case-based training course and 2) a dialog tool including a symptom assessment scale to be used in a structured consultation at the nursing home.CONCLUSION: This study presents a detailed account of the tailoring process for a complex intervention to optimize deprescribing of antidepressants for older persons with dementia at nursing homes. By presenting a thorough development process, we expect to achieve increased adherence to the intervention which is currently being tested in an ongoing cluster randomized controlled trial. The transparency of the process will also increase the future development of other similar complex interventions.

AB - INTRODUCTION: First-line treatment for behavioral and psychiatric symptoms of dementia is non-pharmacological. Still, psychotropic medication is widely used, despite its limited effect and harmful side-effects. More than half of all nursing home residents with dementia receive antidepressants, even though deprescribing is safe and feasible. Interventions to promote deprescribing of antidepressants in nursing homes are few and complex. To optimize the deprescribing process through an intervention, transparency for the development of the intervention is needed. We aim to describe the steps in the development and tailoring of an intervention targeting GPs, nursing home staff, and relatives to enhance collaboration on reducing the use of antidepressants in institutionalized older persons with dementia in Denmark.METHOD: A step-wise process guided by the core elements in the Medical Research Council constituted the tailoring process. Five steps were included; 1) a literature search, 2) interviews with stakeholders, 3) drafting the intervention prototype, 4) professionals' assessment of the intervention, and 5) refinement of the intervention. The steps were conducted from June 2020 to June 2022.RESULTS: Based on the literature search, interviews with stakeholders, and professionals' assessment of the intervention, four main themes were identified; 1) focusing on antidepressants, 2) importance of professional qualifications, 3) collaboration and communication, and 4) patient and relative involvement. They guided intervention development and refinement of the final intervention, which included 1) a case-based training course and 2) a dialog tool including a symptom assessment scale to be used in a structured consultation at the nursing home.CONCLUSION: This study presents a detailed account of the tailoring process for a complex intervention to optimize deprescribing of antidepressants for older persons with dementia at nursing homes. By presenting a thorough development process, we expect to achieve increased adherence to the intervention which is currently being tested in an ongoing cluster randomized controlled trial. The transparency of the process will also increase the future development of other similar complex interventions.

KW - Humans

KW - Aged

KW - Aged, 80 and over

KW - Nursing Homes

KW - Antidepressive Agents/therapeutic use

KW - Psychotropic Drugs/therapeutic use

KW - Longitudinal Studies

KW - Dementia/therapy

U2 - 10.1186/s12913-022-08961-9

DO - 10.1186/s12913-022-08961-9

M3 - Journal article

C2 - 36572903

VL - 22

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 1582

ER -

ID: 330462101